[Application of pegylated recombinant human granulocyte colony-stimulating factor to prevent chemotherapy-induced neutropenia in patients with lymphoma: a prospective, multicenter, open-label clinical trial]. [electronic resource]

By: Contributor(s): Producer: 20190219Description: 825-830 p. digitalISSN:
  • 0253-2727
Subject(s): Online resources: In: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi vol. 38
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Clinical Trial, Phase IV; Journal Article; Multicenter Study

There are no comments on this title.

to post a comment.